We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
iRadimed
IRMD
$1.21B
| $246K | ﹤0.01% |
5,459
-29,121
| -84% | -$1.35M |
|
|
FSRXW
3002
CALL
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
| $244K | ﹤0.01% |
24,996
| – | – |
|
|
WMC
3003
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $244K | ﹤0.01% |
14,260
+12,211
| +596% | +$239K |
|
3004
Boise Cascade
BCC
$2.83B
| $243K | ﹤0.01% |
3,506
-15,263
| -81% | -$1.15M |
|
3005
Astronics
ATRO
$3.37B
| $242K | ﹤0.01% |
+22,585
| New | +$246K |
|
3006
InMode
INMD
$889M
| $242K | ﹤0.01% |
+6,564
| New | +$294K |
|
3007
OFS Capital
OFS
$45.3M
| $242K | ﹤0.01% |
+18,721
| New | +$201K |
|
3008
Alico
ALCO
$284M
| $241K | ﹤0.01% |
+6,433
| New | +$224K |
|
3009
Vertex
VERX
$2.14B
| $240K | ﹤0.01% |
+15,688
| New | +$219K |
|
|
SUM
3010
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $240K | ﹤0.01% |
+7,857
| New | +$262K |
|
3011
CVRx
CVRX
$131M
| $236K | ﹤0.01% |
+39,222
| New | +$317K |
|
3012
Dover
DOV
$27.4B
| $236K | ﹤0.01% |
+1,514
| New | +$248K |
|
3013
St. Joe Company
JOE
$3.57B
| $235K | ﹤0.01% |
+3,962
| New | +$205K |
|
3014
Lantronix
LTRX
$238M
| $235K | ﹤0.01% |
35,143
-14,562
| -29% | -$104K |
|
|
MILEW
3015
CALL
DELISTED
Metromile, Inc. Warrant
MILEW
| $235K | ﹤0.01% |
177,450
| – | – |
|
|
LUNA
3016
DELISTED
Luna Innovations Incorporated
LUNA
| $234K | ﹤0.01% |
+30,327
| New | +$218K |
|
3017
The ONE Group
STKS
$55.6M
| $233K | ﹤0.01% |
+22,132
| New | +$260K |
|
3018
Cass Information Systems
CASS
$715M
| $232K | ﹤0.01% |
+6,266
| New | +$250K |
|
|
IAS
3019
DELISTED
Integral Ad Science
IAS
| $232K | ﹤0.01% |
+16,744
| New | +$285K |
|
3020
Syntec Optics
OPTX
$257M
| $232K | ﹤0.01% |
+23,314
| New | +$232K |
|
3021
Stewart Information Services
STC
$2.12B
| $232K | ﹤0.01% |
+3,840
| New | +$267K |
|
3022
Invesco China Technology ETF
CQQQ
$3B
| $231K | ﹤0.01% |
+4,903
| New | +$270K |
|
|
DFS
3023
DELISTED
Discover Financial Services
DFS
| $231K | ﹤0.01% |
2,100
-3,591
| -63% | -$422K |
|
|
SBDS
3024
DELISTED
Solo Brands Inc
SBDS
| $231K | ﹤0.01% |
675
-2,029
| -75% | -$898K |
|
3025
Kadant
KAI
$3.72B
| $230K | ﹤0.01% |
+1,187
| New | +$243K |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.